Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery

Area of Science:

• Immunology
• Molecular Biology
• Pathology

Background:

• Human studies confirm macrophage migration inhibitory factor (MIF) involvement in various diseases beyond initial animal models.
• Elevated MIF levels are observed in sepsis, rheumatoid arthritis, glomerulonephritis, inflammatory lung disease, ulcerative colitis, inflammatory neurological diseases, and cancer.

Purpose of the Study:

• To summarize recent findings on MIF's role in human diseases.
• To explore MIF's cellular targets and molecular interactions.
• To investigate potential therapeutic applications based on MIF's structure and function.

Main Methods:

• Review of recent human studies on MIF.
• Analysis of cellular studies detailing MIF's effects on immune and non-immune cells.
• Examination of molecular studies on MIF interactions with intracellular proteins (Jab1, PAG, p53).
• Structural analysis of MIF to identify potential functional sites.

Main Results:

• MIF's involvement is confirmed in a growing list of human inflammatory diseases and cancer.
• MIF influences the activity of macrophages, T cells, natural killer cells, fibroblasts, and endothelial cells.
• Direct interactions between MIF and regulatory proteins controlling cell growth (Jab1, PAG, p53) have been identified.
• The three-dimensional structure of MIF reveals potential enzymatic sites.

Conclusions:

• MIF plays a significant role in diverse human pathologies, including inflammatory diseases and cancer.
• MIF's broad cellular effects and molecular interactions contribute to its pathological roles.
• Identified structural features and enzymatic sites of MIF present promising targets for therapeutic intervention.